Orthofix Medical Q1 EPS $(0.95) Misses $(0.33) Estimate, Sales $188.60M Beat $184.13M Estimate
Portfolio Pulse from Benzinga Newsdesk
Orthofix Medical (NASDAQ:OFIX) reported Q1 EPS of $(0.95), missing estimates by 187.88% and marking an 850% decrease from last year. However, their sales of $188.60M exceeded estimates by 2.43%, showing a 7.65% year-over-year increase.
May 07, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Orthofix Medical's Q1 earnings missed estimates significantly with an EPS of $(0.95), but sales exceeded expectations at $188.60M.
The significant miss in EPS could negatively impact investor sentiment towards OFIX, suggesting potential short-term price pressure. However, the beat on sales might offset some of the negative impact by indicating underlying business strength. The mixed results lead to a neutral short-term price direction score.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100